Patents by Inventor Phil Xiang

Phil Xiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnosis and treatment of cancer using mammalian pellino polypeptides and polynucleotides
    Patent number: 7115368
    Abstract: The present invention provides methods, reagents, and kits for diagnosing and treating cancer in a mammal, e.g., a human. This invention is based upon the discovery that Pellino 1 or 2 is overexpressed and/or amplified in cancer. Methods to detect cancer or a propensity to develop cancer, to monitor the efficacy of a cancer treatment, and to treat cancer, by inhibiting the expression and/or activity of Pellino 1 or 2 in a cancer cell are included.
    Type: Grant
    Filed: December 28, 2001
    Date of Patent: October 3, 2006
    Assignee: Amgen SF, LLC
    Inventors: Scott Powers, David Mu, Phil Xiang, Yue Peng
  • PRC17: an amplified cancer gene
    Publication number: 20030044814
    Abstract: The present invention provides nucleic acid and protein sequences for a novel protein, PRC17, and methods, reagents, and kits for diagnosing and treating cancer in a mammal, e.g., a human. This invention is based upon the discovery that the novel PRC17 is overexpressed and/or amplified in cancer. Methods to detect cancer or a propensity to develop cancer, to monitor the efficacy of a cancer treatment, and to treat cancer, by inhibiting the expression and/or activity of PRC17 in a cancer cell are included.
    Type: Application
    Filed: February 8, 2002
    Publication date: March 6, 2003
    Applicant: Tularik Inc.
    Inventors: Jing Li, Scott Powers, Phil Xiang, Yue Peng
  • Diagnosis and treatment of cancer using mammalian pellino polypeptides and polynucleotides
    Publication number: 20020150934
    Abstract: The present invention provides methods, reagents, and kits for diagnosing and treating cancer in a mammal, e.g., a human. This invention is based upon the discovery that Pellino 1 or 2 is overexpressed and/or amplified in cancer. Methods to detect cancer or a propensity to develop cancer, to monitor the efficacy of a cancer treatment, and to treat cancer, by inhibiting the expression and/or activity of Pellino 1 or 2 in a cancer cell are included.
    Type: Application
    Filed: December 28, 2001
    Publication date: October 17, 2002
    Applicant: Tularik Inc.
    Inventors: Scott Powers, David Mu, Phil Xiang, Yue Peng